325 related articles for article (PubMed ID: 21810280)
1. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
Pender MP; Csurhes PA; Pfluger CM; Burrows SR
BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280
[TBL] [Abstract][Full Text] [Related]
2. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
Pender MP; Csurhes PA; Lenarczyk A; Pfluger CM; Burrows SR
J Neurol Neurosurg Psychiatry; 2009 May; 80(5):498-505. PubMed ID: 19015225
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients.
Jørgensen PB; Livbjerg AH; Hansen HJ; Petersen T; Höllsberg P
PLoS One; 2012; 7(9):e46120. PubMed ID: 23049954
[TBL] [Abstract][Full Text] [Related]
5. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
[TBL] [Abstract][Full Text] [Related]
6. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
Jilek S; Schluep M; Harari A; Canales M; Lysandropoulos A; Zekeridou A; Pantaleo G; Du Pasquier RA
J Immunol; 2012 May; 188(9):4671-80. PubMed ID: 22461701
[TBL] [Abstract][Full Text] [Related]
7. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
Veroni C; Aloisi F
Front Immunol; 2021; 12():665718. PubMed ID: 34305896
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
van Nierop GP; Mautner J; Mitterreiter JG; Hintzen RQ; Verjans GM
Mult Scler; 2016 Mar; 22(3):279-91. PubMed ID: 26041797
[TBL] [Abstract][Full Text] [Related]
10. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
Angelini DF; Serafini B; Piras E; Severa M; Coccia EM; Rosicarelli B; Ruggieri S; Gasperini C; Buttari F; Centonze D; Mechelli R; Salvetti M; Borsellino G; Aloisi F; Battistini L
PLoS Pathog; 2013; 9(4):e1003220. PubMed ID: 23592979
[TBL] [Abstract][Full Text] [Related]
11. High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.
Lossius A; Johansen JN; Vartdal F; Robins H; Jūratė Šaltytė B; Holmøy T; Olweus J
Eur J Immunol; 2014 Nov; 44(11):3439-52. PubMed ID: 25103993
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Pender MP; Csurhes PA; Pfluger CM; Burrows SR
Mult Scler; 2014 Dec; 20(14):1825-32. PubMed ID: 24842963
[TBL] [Abstract][Full Text] [Related]
13. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
Höllsberg P; Hansen HJ; Haahr S
Clin Exp Immunol; 2003 Apr; 132(1):137-43. PubMed ID: 12653848
[TBL] [Abstract][Full Text] [Related]
14. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle.
Croft NP; Shannon-Lowe C; Bell AI; Horst D; Kremmer E; Ressing ME; Wiertz EJ; Middeldorp JM; Rowe M; Rickinson AB; Hislop AD
PLoS Pathog; 2009 Jun; 5(6):e1000490. PubMed ID: 19557156
[TBL] [Abstract][Full Text] [Related]
16. Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.
Fogg MH; Wirth LJ; Posner M; Wang F
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3318-23. PubMed ID: 19211798
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Pender MP; Csurhes PA; Smith C; Beagley L; Hooper KD; Raj M; Coulthard A; Burrows SR; Khanna R
Mult Scler; 2014 Oct; 20(11):1541-4. PubMed ID: 24493474
[TBL] [Abstract][Full Text] [Related]
18. Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA-DR15.
Zdimerova H; Murer A; Engelmann C; Raykova A; Deng Y; Gujer C; Rühl J; McHugh D; Caduff N; Naghavian R; Pezzino G; Capaul R; Zbinden A; Ferlazzo G; Lünemann JD; Martin R; Chatterjee B; Münz C
Eur J Immunol; 2021 Jan; 51(1):64-75. PubMed ID: 32949466
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.
Cárdenas D; Vélez G; Orfao A; Herrera MV; Solano J; Olaya M; Uribe AM; Saavedra C; Duarte M; Rodríguez M; López M; Fiorentino S; Quijano S
Clin Exp Immunol; 2015 Nov; 182(2):173-83. PubMed ID: 26174440
[TBL] [Abstract][Full Text] [Related]
20. Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.
Keane JT; Afrasiabi A; Schibeci SD; Fewings N; Parnell GP; Swaminathan S; Booth DR
Front Immunol; 2021; 12():732694. PubMed ID: 34566997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]